Results 21 to 30 of about 51,167 (210)
A 55 year old woman was admitted because of a slowly growing chest mass. A diagnosis of giant cells tumor (GCT) was made. In sharp contrast to other large bone metaphysis it accounts for < 1 % of all primary rib's neoplasias. The resection included one normal adjacent rib above and below the tumour with all intervening intercostals muscles and pleura ...
Juan C. Collado Otero +2 more
openaire +1 more source
HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis [PDF]
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study we examined cell-cycle proteins expression and correlation with human papillomavirus infection in a series of 15 pure penile verrucous ...
A Ouban +58 more
core +1 more source
Background: Giant cell tumours are common primary long bone tumours with femoral neck locations infrequent and notorious for pathological fractures. Treatment with simple curettage often results in local recurrence.
S. Abdulrazak +4 more
doaj +1 more source
Imaging features of rare mesenychmal liver tumours: beyond haemangiomas. [PDF]
Tumours arising from mesenchymal tissue components such as vascular, fibrous and adipose tissue can manifest in the liver. Although histopathology is often necessary for definitive diagnosis, many of these lesions exhibit characteristic imaging features.
Ahmed, Kareem +7 more
core +3 more sources
Tenosynovial giant cell tumour (localized type) is a tumour of tendon sheaths and interphalangeal joints, affecting the digits and arising from the synovium.
V. Caputo, S. Fiorella, E. Orlando
doaj +1 more source
The small molecule ephrin receptor inhibitor, GLPG1790, Reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models [PDF]
Therapies against glioblastoma (GBM) show a high percentage of failure associated with the survival of glioma stem cells (GSCs) that repopulate treated tumours.
Beirinckx, Filip +15 more
core +2 more sources
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases. [PDF]
Denosumab has been used successfully to treat disease-associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central ...
Bernthal, Nicholas M +8 more
core +2 more sources
Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells [PDF]
Retinoid treatment is employed during residual disease treatment in neuroblastoma, where the aim is to induce neural differentiation or death in tumour cells.
Bilip, Maja +11 more
core +4 more sources
Current indications for denosumab in benign bone tumours
Denosumab is a fully humanised monoclonal antibody to RANK ligand, inhibiting the RANK–RANKL pathway. It promotes the apoptosis of osteoclast-like giant cells, a secondary ossification and connective tissue formation. Given its high efficacy, denosumab
Antal Imre +2 more
doaj +1 more source
Self-assessment: weight loss and anorexia in a Fox Terrier [PDF]
No abstract ...
Anguita, Antonio
core +1 more source

